Hookipa Biotech is a clinical stage company developing next-generation immunotherapies for infectious diseases and cancer using novel proprietary arenavirus vector platforms. Hookipa´s TheraT® and Vaxwave® platforms have shown promising abilities to elicit high neutralizing antibody responses, but also necessary levels of T cell responses, currently missing in most vaccine and therapeutic approaches. Hookipa’s vectors are not impeded by vector-neutralizing antibodies and can be administered repeatedly, providing even greater immune protection. Levels of specific T cells generated by TheraT® are unprecedented in the field and have the potential to transform active immune-therapy in cancers. Hookipa has completed the active phase of a Phase 1 trial of a Vaxwave®-based vaccine against cytomegalovirus (CMV) and is finalizing clinical development plans for TheraT® in Human Papilloma Virus (HPV)- related head and neck cancers.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
10
Frequently Asked Questions
What is the 52-week high for Hookipa Pharma Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Hookipa Pharma Inc 52 week high is $1.65 as of June 08, 2026.
What is the 52-week low for Hookipa Pharma Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Hookipa Pharma Inc 52 week low is $0.811 as of June 08, 2026.
What is Hookipa Pharma Inc stock price today?
Hookipa Pharma Inc stock price today is $1.15.
What was Hookipa Pharma Inc stock price yesterday?
Hookipa Pharma Inc stock price yesterday was $1.14.
What is the PE ratio of Hookipa Pharma Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Hookipa Pharma Inc's P/E ratio is -0.25.
What is the Price-to-Book ratio of Hookipa Pharma Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Hookipa Pharma Inc P/B ratio is 0.489.
What is the 50-day moving average of Hookipa Pharma Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Hookipa Pharma Inc 50-day moving average is $1.14.